Perjeta, formally called pertuzumab, represents a crucial advancement in addressing HER2-positive certain types of cancer. The medication works by blocking a specific pathway which helps cancer cells grow . Unlike some other HER2-targeted therapies, pertuzumab doesn’t directly get more info block th